🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Patrick Kwok‐Shing Ng

University of Connecticut

ORCID: 0000-0003-0364-7443

Also affiliated with Jackson Laboratory, The Jackson Laboratory for Genomic Medicine

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations”.

Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.05.021
N/A
0.646DataRank · unranked
73 citations

Victoria M. Raymond, Richard B. Lanman, Jacqulyne Robichaux, Junqin He, Monique B. Nilsson +17 more

Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Genome biology(2020)10.1186/s13059-020-01954-z
N/A
0.624DataRank · unranked
63 citations

Jun Li, Yumeng Wang, Patrick Kwok‐Shing Ng, Yiu Huen Tsang, Kenna Shaw +3 more

A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies

Nature Cancer(2024)10.1038/s43018-024-00817-x
N/A
0.449DataRank · unranked
19 citations

Wei Liu, Kamalika Mojumdar, Hong Kim, Zhicheng Zhou, Zhenlin Ju +9 more

Immunosuppressive tumor microenvironment of osteosarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.01.565008
N/A
0DataRank · unranked
2 citations

Jianting Sheng, Patrick Kwok‐Shing Ng, Jeffrey M. Harder, Parveen Kumar, Ju Young Ahn +23 more

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

Research Square(2022)10.21203/rs.3.rs-2248209/v1
N/A
0DataRank · unranked
0 citations

Turçin Saridogan, Argun Akçakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca +11 more

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2021)10.1172/jci150335
N/A
0DataRank · unranked
60 citations

Bhumsuk Keam, Janice Cho, Michelle J. Lee, Hye Ryun Kim, Hayarpi Torosyan +16 more

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

Scientific Reports(2023)10.1038/s41598-023-46586-y
N/A
0DataRank · unranked
15 citations

Argun Akçakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca, Stephen Scott +11 more